MedTrace Logo

Trial of Simplified Pneumococcal Vaccination in Vietnam II

NCT03098628 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 2501

Last updated 2024-11-27

No results posted yet for this study

Summary

This is a single-blind, open-label, randomised controlled trial with five groups. There are four different Pneumococcal Conjugate Vaccine (PCV) schedules to be evaluated.

Conditions

  • Pneumococcal Vaccine

Interventions

BIOLOGICAL

PCV Vaccine

PCV vaccination

Sponsors & Collaborators

  • Pasteur Institute, Ho Chi Minh City

    collaborator OTHER_GOV

  • Murdoch Childrens Research Institute

    lead OTHER

Principal Investigators

  • Kim Mulholland, MD · Murdoch Childrens Research Institute

  • Nguyen Vu Thuong, MD · Pasteur Institute

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
8 Weeks
Max Age
10 Weeks
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2017-03-08
Primary Completion
2020-06-11
Completion
2020-06-11

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03098628 on ClinicalTrials.gov